Comprehensive Endometrial Cancer Program

Endometrial Cancer Today

Endometrial cancer is the most common gynecologic cancer. It starts in the endometrium –the lining of the uterus. Over the last 15 years, incidence and mortality are rising in Canada. Although the disease has been considered one of older individuals, there is a growing number of cases among younger patients aged 30 to 49. The survival rate for advanced disease remains poor at around 15%.

Comprehensive Endometrial Cancer Program

Our comprehensive program is working towards the following objectives

  1. Ensure timely diagnosis. The time for a patient to wait for biopsy following symptoms, get assessed and then referred to the appropriate doctor can often take months. There is evidence that longer wait times between diagnosis and surgical treatment can cause a significant decline in cancer survival. We aim to establish a Rapid Diagnosis Clinic to provide an easy, streamlined referral process for all patients with symptoms to get access to an in-office biopsy to ensure timely diagnosis and improve outcomes
  2. Personalize care for each patient. Our program aims to perform molecular characterization to help classify tumour subtypes based on their genetic make-up. This will help direct tailored treatment decisions, and help determine who can participate in clinical trials.
  3. Offer cutting-edge surgical treatment. Our program’s gynecologic oncologists are world-renowned, high-volume minimally invasive surgeons with expertise in advanced surgical techniques and robotic platforms. Our program provides advanced oncologic surgeries with same day discharge, so patients can recover in the comfort of their own home.
  4. Translate innovations into the clinic. Our program continues to lead international practice-changing work, which offers advanced endometrial cancer patients less invasive ways to learn how far their cancer has spread. The team is also exploring new ways to identify widespread cancer through pre-clinical models that will soon be trialed in humans, used before and during surgery to detect disease and tailor therapy.